N-(3,3-DIPHENYLPROPYL)-α-METHYLPHENETHYLAMIN LACTATE SALT

Names

[ CAS No. ]:
69-43-2

[ Name ]:
N-(3,3-DIPHENYLPROPYL)-α-METHYLPHENETHYLAMIN LACTATE SALT

[Synonym ]:
Prenylaminlactat
incoran
corontin
roinin
(3-Phenyl-2-propyl)(3.3-diphenylpropyl)amin*Milchsaeure
crepasin
coredamin
Prenylamine lactate
angormin
agozol
reocorin
seccidin
irrorin

Chemical & Physical Properties

[ Boiling Point ]:
340.2ºC at 760 mmHg

[ Molecular Formula ]:
C₂₈H₃₅NO₂

[ Molecular Weight ]:
417.58300

[ Flash Point ]:
159.5ºC

[ Exact Mass ]:
417.26700

[ PSA ]:
49.33000

[ LogP ]:
5.77650

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: SH6490000

CHEMICAL NAME :: Phenethylamine, N-(3,3-diphenylpropyl)-alpha-methyl-, lactate

CAS REGISTRY NUMBER :: 69-43-2

LAST UPDATED :: 199309

DATA ITEMS CITED :: 5

MOLECULAR FORMULA :: C24-H27-N.C3-H6-O3

MOLECULAR WEIGHT :: 419.61

WISWESSER LINE NOTATION :: RYR&2MY1&1R &QVYQ1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,2127,1976

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 40 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,2127,1976

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 250 mg/kg

TOXIC EFFECTS :: Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - acute pulmonary edema Lungs, Thorax, or Respiration - other changes

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 10,569,1960

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 40 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,2127,1976

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 680 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,716,1982

Safety Information

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
20/21/22-36/37/38

Related Compounds

6-(3-chloro-4-methyl-phenyl)-7-isopropyl-2-methyl-3H-quinazolin-4-one
2-[(difluoromethyl)sulfanyl]-5-(2-hydroxyethyl)-6-methyl-4(3H)-pyrimidinone
5-[[3-[2-Amino-3-cyano-6-(2-hydroxy-6-methoxyphenyl)-4-pyridinyl]phenyl]amino]-4-hydroxy-5-oxopentanoic acid
5-(4-(dimethylamino)phenyl)-2-(ethylthio)-8,8-dimethyl-7,8,9,10-tetrahydropyrimido[4,5-b]quinoline-4,6(3H,5H)-dione
(E)-3-(3-methoxyphenyl)-2-(4-oxo-3,4-dihydroquinazolin-2-yl)acrylonitrile
2-((4-oxo-1-phenyl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)thio)-N-(o-tolyl)acetamide
N-(4-(sec-Butyl)phenyl)-2-(ethyl((4-oxo-3,4-dihydroquinazolin-2-yl)methyl)amino)acetamide
Ethyl 1-[(6,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)methyl]piperidine-4-carboxylate
4-[3-(4-methoxyphenyl)-1H-1,2,4-triazol-5-yl]phenol
2-[3-(3-nitrophenyl)-1H-1,2,4-triazol-5-yl]phenol

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.